GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Accounts Payable

Sumitomo Pharma Co (Sumitomo Pharma Co) Accounts Payable : $452 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Accounts Payable?

Sumitomo Pharma Co's Accounts Payable for the quarter that ended in Mar. 2024 was $452 Mil.

Sumitomo Pharma Co's quarterly Accounts Payable declined from Sep. 2023 ($390 Mil) to Dec. 2023 ($350 Mil) but then increased from Dec. 2023 ($350 Mil) to Mar. 2024 ($452 Mil).

Sumitomo Pharma Co's annual Accounts Payable increased from Mar. 2022 ($389 Mil) to Mar. 2023 ($390 Mil) and increased from Mar. 2023 ($390 Mil) to Mar. 2024 ($452 Mil).

Sumitomo Pharma Co Accounts Payable Historical Data

The historical data trend for Sumitomo Pharma Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Accounts Payable Chart

Sumitomo Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 578.18 594.65 389.48 390.09 452.01

Sumitomo Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 390.09 327.74 390.36 349.94 452.01

Sumitomo Pharma Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Sumitomo Pharma Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Accounts Payable
Comparable Companies
TSE:4540 TSE:4887 TSE:4547 TSE:4521 TSE:4534 TSE:4553 TSE:4569 TSE:4551 TSE:4559 TSE:4886 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
4506:Japan DPM:Germany
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
https://www.sumitomo-pharma.com
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.